GMO PRIME STRATEGY CO. LTD.

As of May 31, 2026, GMO PRIME STRATEGY CO. LTD. carries a market capitalization of 4.23B, placing it among publicly traded companies globally. Its enterprise value stands at 3.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GMO PRIME STRATEGY CO. LTD.'s next confirmed earnings release is scheduled for January 20, 2027.

As of May 31, 2026, GMO PRIME STRATEGY CO. LTD. has 3.53M shares outstanding.

These figures are as of May 31, 2026.

As of May 31, 2026, GMO PRIME STRATEGY CO. LTD. maintains a current ratio of 7.82, meaning it holds 7.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended May 31, 2026.

As of the close on October 22, 2026, GMO PRIME STRATEGY CO. LTD.'s stock has gained approximately 53.06% over the past 52 weeks. The 50-day moving average sits at 1,072.50, while the 200-day moving average is 1,101.99.

As of May 31, 2026, GMO PRIME STRATEGY CO. LTD. holds 1.19B in cash and equivalents against 44.22M in total debt, resulting in a net debt position of -1.15B. Total book value stands at 1.40B, with working capital of 1.16B providing operational flexibility.